Literature DB >> 8588142

Analysis of restriction fragment length polymorphism and ribotyping of multiresistant Stenotrophomonas maltophilia isolated from persisting lung infection in a cystic fibrosis patient.

J Wüst1, R Frei, H Günthard, M Altwegg.   

Abstract

A cystic fibrosis patient was infected by Stenotrophomonas maltophilia over at least 15 months. The bacteria became increasingly resistant to antimicrobial agents. Determination of restriction fragment length polymorphism and ribotyping showed that resistance was due to changes in that S. maltophilia rather than to infection by another strain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8588142     DOI: 10.3109/00365549509047053

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  6 in total

1.  Antibiotic resistance of Stenotrophomonas maltophilia strains isolated from captive snakes.

Authors:  P Hejnar; M Kolár; P Sauer
Journal:  Folia Microbiol (Praha)       Date:  2010-03-25       Impact factor: 2.099

2.  Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR.

Authors:  P W Whitby; K B Carter; J L Burns; J A Royall; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 3.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia.

Authors:  G Berg; N Roskot; K Smalla
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

5.  Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998.

Authors:  S Valdezate; A Vindel; L Maiz; F Baquero; H Escobar; R Cantón
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

6.  Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model.

Authors:  Boubakar B Ba; Hala Feghali; Corinne Arpin; Marie-Claude Saux; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.